Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Nov 1;192(9):1557-65.
doi: 10.1086/491742. Epub 2005 Sep 29.

Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women

Affiliations
Comparative Study

Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women

Marek J Nowicki et al. J Infect Dis. .

Abstract

Background: Hepatitis C virus (HCV)-infected women--in particular, those coinfected with human immunodeficiency virus type 1 (HIV-1)--can transmit infection to their children and sex partners.

Methods: The present study was conducted to analyze the presence of HCV RNA in cervicovaginal lavage (CVL) fluid from 71 women (58 HCV/HIV-1-coinfected women and 13 HCV-infected, HIV-1-uninfected women) enrolled in the Women's Interagency HIV Study.

Results: HCV RNA was detected (by a commercial polymerase chain reaction assay) in CVL fluid from 18 (29%) of the HIV-1-infected women and from none of the HIV-1-uninfected women (P<.05). Multivariate analysis revealed that risk factors for the presence of HCV RNA in CVL fluid were HCV viremia (odds ratio [OR], 16.81; P=.02) and HIV-1 RNA in CVL fluid (OR, 19.87; P=.02). This observation suggests local interactions between HIV-1 and HCV in the genital tract compartment. There was no correlation between HCV RNA in CVL fluid and CD4, CD8, or CD3 cell counts, HIV-1 RNA viremia, the number of leukocytes in CVL fluid, or HIV-1 therapy. Furthermore, in 3 of 5 analyzed patients who had a detectable CVL HCV RNA load, we found viral variants differing in the 5' untranslated region that were present neither in plasma nor in peripheral-blood mononuclear cells.

Conclusions: Our observations point to the importance of the genital tract compartment, in which local HCV replication could be facilitated by local HIV-1 replication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationships between HIV-1 and hepatitis C virus (HCV) RNA loads in plasma and detectability of HCV RNA (A) and HIV-1 RNA (B) loads in cervicovaginal lavage (CVL) fluid. In the figure, circles indicate undetectable CVL HCV (A) or HIV-1 (B) loads, and triangles indicate detectable CVL HCV (A) or HIV-1 (B) loads. For the relationship between HIV-1 RNA load in CVL fluid and plasma, Pearson’s R = 0.50 (P = .0003); for the relationship between HCV RNA load in CVL fluid and plasma, Pearson’s R = 0.33 (P = .0111).
Figure 2
Figure 2
Single-strand conformation polymorphism analysis of plasma-, cervicovaginal lavage (CVL)–, and peripheral-blood mononuclear cell (PBMC)– derived 5′ untranslated region hepatitis C virus (HCV) sequences. CVL neg str, HCV RNA negative strand in CVL fluid.
Figure 3
Figure 3
Comparison of 5′ untranslated region hepatitis C virus (HCV) sequences amplified from plasma, cervicovaginal lavage (CVL) fluid, and peripheral-blood mononuclear cells (PBMCs) in patients 6, 7, and 9. In the figure, a minus sign indicates HCV RNA negative strand; “CVL” indicates the dominant variant; “CVL1,” “CVL2,” and “CVL3” indicate minor variants; and the nos. in parentheses indicate the no. of clones representing a given sequence.

Similar articles

Cited by

References

    1. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1993;6:602–10. - PubMed
    1. Garcia-Samaniego J, Soriano V, Castilla J, et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. Am J Gastroenterol. 1997;92:1130–4. - PubMed
    1. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800–5. - PubMed
    1. Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12:381–8. - PubMed
    1. Alter H. Discovery of non-A, non-B hepatitis and identification of its etiology. Am J Med. 1999;107(Suppl):S16–20. - PubMed

Publication types

MeSH terms